Riccardo Pozzan
Pordenone, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Dual REmission in moderate-to-severe AsthMa and nasal polyps: a multicentric observational phase IV real-life study (DREAM-NP).
Journal: Expert opinion on biological therapy
Published: July 24, 2026
Autoantibodies in sarcoidosis: Innocent bystander or promising biomarker for organ involvement?
Journal: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Published: May 18, 2024
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 14, 2023
Advances in Diagnostics and Management of Respiratory System Diseases.
Journal: Diagnostics (Basel, Switzerland)
Published: December 04, 2023
Editorial: Evolution in respiratory pharmacology.
Journal: Frontiers in pharmacology
Published: October 29, 2023
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation.
Journal: Diagnostics (Basel, Switzerland)
Published: August 02, 2023
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 03, 2023
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy.
Journal: Diagnostics (Basel, Switzerland)
Published: April 23, 2023
Host-Based Treatments for Severe COVID-19.
Journal: Current issues in molecular biology
Published: March 03, 2023
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 18, 2022
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story?
Journal: Heliyon
Published: September 18, 2022
Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS).
Journal: The European respiratory journal
Published: August 01, 2022
Last Updated: 09/26/2026